Review Article | 06 January 2025 Immunotherapy for advanced-stage squamous cell lung cancer: the state of the art and outstanding questions Despite lower levels of most targetable alterations, a strong association with a history of smoking and generally higher levels of PD-L1 expression, patients...
checkpoint blockade immunotherapies. Accumulating evidence indicates that a loss of effective anti-tumor immunity is associated with lung tumor evolution. Therapeutic cancer vaccines combined with immune checkpoint inhibitors (ICI) can achieve better therapeutic effects. To this end, the present article enco...
Review Article: Advances in Immunotherapy for Non–Small Cell Lung CancerKaren L. Reckamp
Review Article|19 April 2022 Engineered cellular immunotherapies in cancer and beyond Oncology is trailblazing the field of engineered cellular therapeutics. This Review discusses the goals of cellular immunotherapy in cancer, key challenges facing the field and strategies to overcome them—paving the way...
In this article, we discuss studies focusing on interactions between lung cancer and the immune system, and we place an emphasis on outcome evidence in order to create a knowledge base well-grounded in clinical reality. Overall, this review highlights the need for new lung cancer treatment ...
Lung cancer is one of the malignant tumors with the fastest increasing morbidity and mortality in the world.Although surgical techniques have been improved... QH Li,ZZ Liu - 《Tmr肿瘤进展》 被引量: 0发表: 2022年 review article cancer immunotherapy: priming the host immune response with live ...
Recent immunotherapy approaches have focused on antibodies that block immune checkpoints, and these approaches have produced significant clinical responses in melanoma, lung cancer and kidney cancer. The authors of this Review briefly review the basic im
Lung cancer: potential targets for immunotherapy. Lancet Respir Med. 2013;1:551–63. : 10.1016/s2213-2600(13)70159-0 .Tartour E, Zitvogel L. Lung cancer: potential targets for immunotherapy. Lancet Respir Med. 2013;1:551-63.EricTartour, LaurenceZitvogel. (2013) Lung cancer: potential ...
These successes have renewed interest in cancer immunotherapy. This Review summarizes recent work on vaccines, T-cell immunomodulators and other active immunostimulants that, together with targeted therapies, could lead to cancer therapies in years to come.show all Access this article Log in via an...
Journal for ImmunoTherapy of Cancer https://doi.org/10.1186/s40425-019-0690-1 (2019) 7:205 REVIEW Open Access Immunotherapy in small-cell lung cancer: from molecular promises to clinical challenges A. Pavan1,2, I. Attili1,2, G. Pasello1, V. Guarneri1,2, P. F. Conte1,2 and L. ...